Project Grant R01NS139524

Award Date 6/1/25
Completion Date 5/31/30
Dollars Obligated $658K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $555,499 to The Leland Stanford Junior University (Stanford University) from December 1, 2024 to November 30, 2029. The project aims to develop and test novel, non-invasive behavioral biomarkers that can predict chronic seizures and mortality in mouse models of temporal...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $426,250 Project Grant under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. This 2-year grant will fund research using cutting-edge voltage imaging to examine how interactions between specific neuronal circuit elements in the hippocampus relate to the development of temporal lobe...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 5-year, $690,763 Project Grant (CFDA 93.853: Extramural Research Programs in the Neurosciences and Neurological Disorders) to Brigham & Women's Hospital Inc. to optimize neuromodulation therapies for epilepsy patients. The project aims to identify factors that determine patient response to Responsive Neurostimulation (RNS), a treatment for drug-resistant epilepsy, focusing on 3 key objectives: 1) analyzing...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $535,389 to support research aimed at understanding the molecular pathways regulating GABAergic inhibition and seizure susceptibility. The research, led by the Children's Hospital Corporation (doing business as Boston Children's Hospital), will investigate how the FLT3...
The Project Grant award R21NS135482, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to develop a unified paradigm using simultaneous multimodal measurement of scalp EEG and intracranial EEG (iEEG) signals to estimate the electrophysiological networks of the whole brain. This will enable the characterization of seizure onset zones and...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $372,625 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Wisconsin-Madison. The 2-year grant aims to conduct a comprehensive single-cell RNA sequencing study to map gene expression changes in the hippocampus of rat models as they transition from low to high seizure risk states. This pioneering research seeks to identify key...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $225,599.00 to the University of Illinois to study the contributions of sex chromosomes and gonadal hormones in shaping sex differences in epilepsy. The project aims to determine how sex chromosomes and sex hormones influence acute seizure susceptibility, seizure-induced...
The National Science Foundation awarded a $550,000 Project Grant to Northeastern University under the Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a smart seizure prediction system using AI-enabled implantable sensor networks. The system will use embedded artificial intelligence algorithms to enable in-situ medical inference for patients with neurological disorders not treatable with antiepilepsy medications. Northeastern University will develop the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $1,319,282.00 to Yale University to conduct research on personalized seizure forecasting using a precision medicine approach. The key objectives are to: (1) elucidate the relationship between biochemical changes in saliva and electrophysiological features that determine seizure likelihood in...
This $674,409 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program aims to investigate how temporal lobe seizures with different onset patterns propagate through the basal ganglia and evaluate the implications for seizure control. The research will use a non-human primate model to record neural activity in the nucleus accumbens-pallidum...

This $657,958 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund research to investigate the cellular and network mechanisms underlying epilepsy biomarkers and seizures, as well as the neuronal impacts of neuromodulation through electrical stimulation. The primary awardee, Trustees of Boston University, will utilize cutting-edge cellular membrane voltage imaging, optogenetics, and local field potential recordings in epilepsy mouse models to elucidate the mechanisms of epileptic activity, the relationship between spike ripples and seizures, and the effects of different electrical stimulation parameters on these biomarkers and seizures. The goal is to gain insights that can help improve treatment approaches for patients with drug-resistant epilepsy. The award period runs from June 1, 2025 to May 31, 2030.

Generated 6/17/25, 5:22 AM